Odonate Therapeutics Inc
Biotechnology
Healthcare
ODT
37.92M shares
NASDAQ US
traded
05 Jan 2022
open
1.44
52 week high
27.39
high
1.45
52 week low
1.33
low
1.32
growth
-93.35%
previous Close
1.44
P/E ratio
-4
market cap
59.66M
div yield
0
usd
Sep 2021
qoq
revenue
net incoming
-14.00M
36.42 %
eps
-0.37
36.21 %
eps surprise
-362.50 %
net profit margin
-1399700000 %
operating incoming
-4.08M
81.12 %
net change in cash
-15.10M
34.45 %
cash on hand
95.03M
-13.71 %
cost of revenue
top top